<p>Flow cytometric analysis revealed that the Fab tetramer, composed of biotinylated fE75 (A) or fML (B) and streptavidin-Alexa-647, bound to T2 cells incubated with the cognate peptide, but not to control peptides or untreated T2 cells in three separate experiments. In C, a graph of the MFI for several other control peptides against the cognate peptide for each Fab was shown. The staining of HER2/neu positive tumor cell lines by the fE75 and fML tetramers was shown in D and E respectively. The graph of the MFI for one representative experiment from four total was shown in F.</p
Peptide-MHC (pMHC) multimers, usually used as streptavidin-based tetramers, have transformed the stu...
<p>(A) The X-axis indicates APCs with different HLA-DR alleles and Y-axis indicates the percentages ...
<p><b>Copyright information:</b></p><p>Taken from "Generation of functional HLA-DR*1101 tetramers re...
<p>Fabs specific for either E75/HLA-A2 or ML/HLA-A2 molecules were selected by phage-display technol...
A major difficulty in treating cancer is the inability to differentiate between normal and tumor cel...
The development of fluorochrome-conjugated peptide-major histocompatibility complex (pMHC) multimers...
A major difficulty in treating cancer is the inability to differentiate between normal and tumor cel...
<p>SPR binding response curves of fE75 binding E75/HLA-A2 (A) and ML/HLA-A2 (B) and fML binding E75/...
The development of fluorochrome-conjugated peptide–major histocompatibility complex (pMHC) multimer...
<div><p>A major difficulty in treating cancer is the inability to differentiate between normal and t...
To directly assess the binding of exogenous peptides to cell surface-associated MHC class I molecule...
Major histocompatibility complex class I (MHC-1) molecules bind peptide fragments derived from cytos...
The major histocompatibility complex (MHC) class II-asso-ciated Invariant chain (Ii) is present in p...
To demonstrate that antibody-guided targeting of antigenic MHC class I-peptide tetramer on tumor cel...
<p>FACS analysis of anti-CD4 Fab-multimer staining with different anti-CD4 Fab mutants with decreasi...
Peptide-MHC (pMHC) multimers, usually used as streptavidin-based tetramers, have transformed the stu...
<p>(A) The X-axis indicates APCs with different HLA-DR alleles and Y-axis indicates the percentages ...
<p><b>Copyright information:</b></p><p>Taken from "Generation of functional HLA-DR*1101 tetramers re...
<p>Fabs specific for either E75/HLA-A2 or ML/HLA-A2 molecules were selected by phage-display technol...
A major difficulty in treating cancer is the inability to differentiate between normal and tumor cel...
The development of fluorochrome-conjugated peptide-major histocompatibility complex (pMHC) multimers...
A major difficulty in treating cancer is the inability to differentiate between normal and tumor cel...
<p>SPR binding response curves of fE75 binding E75/HLA-A2 (A) and ML/HLA-A2 (B) and fML binding E75/...
The development of fluorochrome-conjugated peptide–major histocompatibility complex (pMHC) multimer...
<div><p>A major difficulty in treating cancer is the inability to differentiate between normal and t...
To directly assess the binding of exogenous peptides to cell surface-associated MHC class I molecule...
Major histocompatibility complex class I (MHC-1) molecules bind peptide fragments derived from cytos...
The major histocompatibility complex (MHC) class II-asso-ciated Invariant chain (Ii) is present in p...
To demonstrate that antibody-guided targeting of antigenic MHC class I-peptide tetramer on tumor cel...
<p>FACS analysis of anti-CD4 Fab-multimer staining with different anti-CD4 Fab mutants with decreasi...
Peptide-MHC (pMHC) multimers, usually used as streptavidin-based tetramers, have transformed the stu...
<p>(A) The X-axis indicates APCs with different HLA-DR alleles and Y-axis indicates the percentages ...
<p><b>Copyright information:</b></p><p>Taken from "Generation of functional HLA-DR*1101 tetramers re...